Mark N. Corrigan
Description On January 5, 2010, the board of directors of CombinatoRx, Incorporated, appointed Mark H.N. Corrigan, M.D., an existing member of the Board, as Chief Executive Officer and President of CombinatoRx. Dr. Corrigan is 52 years old and joined the Board on December 21, 2009 in connection with CombinatoRx completing its merger with Neuromed Pharmaceuticals Inc., where he had served as a director since October 2004. Dr. Corrigan joined U.S.-based specialty pharmaceutical company Sepracor Inc. in 2003 and served as Sepracor Inc.'s Executive Vice President, Research & Development until December 2009. Prior to joining Sepracor Inc., Dr. Corrigan spent 10 years with Pharmacia & Upjohn, most recently as Group Vice President of Global Clinical Research and Experimental Medicine. Dr. Corrigan has been a member of the board of directors and the audit committee of Cubist Pharmaceuticals, Inc. since 2008. Prior to joining the pharmaceutical industry, Dr. Corrigan spent five years in academic research at the University of North Carolina Medical School, focusing on psychoneuroendocrinology. Dr. Corrigan holds a B.A. and an M.D. from the University of Virginia and subsequently received specialty training in psychiatry at Cornell University and Maine Medical Center. To view the detailed information, you need to SUBSCRIBE with us. |
 |